BPC-157 for Tendon Injury Evidence

BPC-157 helped injured Achilles tendons heal stronger in rats, with higher walking scores and more organized collagen by days 14 to 21. A newer 4-week rat repair study found only small gains that could have been due to chance. Human evidence is limited to one small knee pain report, with none in tendons, so standard rehab remains the base for recovery.

What did the Achilles tendon studies find in rats?

Researchers cut the Achilles tendon in rats and gave BPC-157 as a daily abdominal injection. Treated tendons withstood more pulling force before breaking, rats had higher walking scores, and the tendon gap closed with more collagen, the fiber that gives tendons strength, by day 14 rat Achilles cut study. In lab dishes, the peptide supported growth of rat tendon cells when a compound that blocks growth was present.

Researchers then separated the Achilles from the heel bone in rats, an injury that does not heal well on its own. Treated tendons again withstood more pull, rats had higher walking scores, and tissue checks showed more organized collagen and blood vessel growth through day 21 rat tendon-to-bone study. When rats also received a steroid that slows healing, BPC-157 lessened that slowdown.

What do newer studies add?

In a 4-week rat study of sewn Achilles repair, BPC-157 tendons looked a little better and withstood a little more pull, but the difference from untreated tendons did not reach statistical significance, which means it could have been due to chance. In the same study, TB-500 did show a clear strength and tissue benefit, and adding BPC-157 to TB-500 gave no extra benefit 2026 rat repair study.

A 2025 review of 36 studies through June 2024 found the same split. Thirty-five animal studies reported better function, structure or strength after muscle, tendon, ligament or bone injury 2025 orthopedic review. The only human study looked back at 12 patients with unspecified chronic knee pain. Those patients received BPC-157 placed into the joint. The review found no human safety data, while animal safety checks reported no adverse effects.

Should I try it for my tendon recovery?

For tendon recovery now, BPC-157 remains an animal finding with no proven human tendon benefit. It lacks FDA approval and is banned in professional sports, and the review authors flagged contamination risk from unregulated products 2025 orthopedic review.

Your recovery still rests on diagnosis, load management, physical therapy and follow up for tears, ruptures or tendon to bone injuries. If you want help weighing whether a recovery treatment fits your history and goals, you can start your HOD plan through /quiz for clinician review.